Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
Quick Stats
Feb 02, 202654.7
AI Score
HOLD0.32
Volume Ratio
Feb 13, 2026
Next Earnings
16
+ve Days (30d)
12
-ve Days (30d)
NEUP Stock Summary
Last updated Feb 02, 2026
NEUP is currently trading at $4.04, positioned below its 200-day moving average of $7.19, suggesting bearish momentum. The stock has a 52-week range of $3.645 to $21.4.
Technical Analysis: The 50-day moving average stands at $4.11, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.66, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.102, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NEUP at 54.7/100 with a HOLD recommendation.
NEUP (Neuphoria Therapeutics Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.66 |
| CMF (20) | -0.102 |
| ROC (10) | -1.703 |
| ADX (14) | 25.237 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.01 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -77.778 |
| MFI (14) | 47.248 |
NEUP Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NEUP Price vs Max Options Open Interest
NEUP Max Change In Options Open Interest
NEUP Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEUP Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEUP Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEUP Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Neuphoria Therapeutics Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NEUP Moving Averages Analysis
NEUP (Neuphoria Therapeutics Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 4.06 |
| 20 | 4.06 |
| 30 | 3.98 |
| 50 | 4.11 |
| 100 | 7.17 |
| 200 | 7.19 |
NEUP Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 21.6 million |
| Earnings/Share ($) | -4.02 |
| Net Proft Margin (%) | -0.6052 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.07 |
| EPS Estimate Next Year ($) | -3.845 |
| WallStreet Target Price ($) | 9.7667 |
| Most Recent Quarter |